The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CONFIRM: A phase III randomized trial to evaluate the efficacy of nivolumab versus placebo in relapsed mesothelioma.
 
Dean Anthony Fennell
Honoraria - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Clovis Oncology; Lilly; MSD Oncology; Roche
Speakers' Bureau - Boehringer Ingelheim
Research Funding - Astex Pharmaceuticals; Bayer; Boehringer Ingelheim (Inst); Fuji Pharma (Inst); lab21 (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology
 
Emma Victoria Kirkpatrick
No Relationships to Disclose
 
Kelly Cozens
No Relationships to Disclose
 
Sarah Danson
Consulting or Advisory Role - Inca Pharma
Speakers' Bureau - Amgen; Bristol-Myers Squibb
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); MSD (Inst); Sierra Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Gerard G. Hanna
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Dermal Laboratories (Inst)
 
Jason Francis Lester
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; MSD
 
Joanne Lord
Research Funding - Philips Healthcare (Inst)
 
Mavis Nye
No Relationships to Disclose
 
Christian H.H Ottensmeier
Consulting or Advisory Role - Bristol-Myers Squibb; immatics; Merck Sharp & Dohme
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Research Funding - BioNTech (Inst); Bristol-Myers Squibb (Inst); Delcath Systems (Inst); Inovio Pharmaceuticals (Inst); Merck Sharp & Dohme (Inst); Serametrix (Inst); Touchlight Genetics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Delcath Systems; Merck Sharp & Dohme; Roche
Other Relationship - Transgene
 
Peter Wojciech Szlosarek
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Research Funding - Polaris (Inst)
 
Nicola L. Steele
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
 
Daniel T Barnes
No Relationships to Disclose
 
Karan D Vadher
No Relationships to Disclose
 
Tom Maishman
No Relationships to Disclose
 
Stephanie J Hill
No Relationships to Disclose
 
Gareth Griffiths
No Relationships to Disclose